Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes.
Authors:
Open Access
- 1 September 1994
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 180 (3) , 1037-1046
Abstract
The hepatitis B virus (HBV) nucleocapsid antigen (HBcAg) was investigated as a carrier moiety for the immunodominant circumsporozoite (CS) protein repeat epitopes of Plasmodium falciparum and the rodent malaria agent P. berghei. For this purpose hybrid genes coding for [NANP]4 (C75CS2) or [DP4NPN]2 (C75CS1) as internal inserts in HBcAg (between amino acids 75 and 81) were constructed and expressed in recombinant Salmonella typhimurium. The resulting hybrid HBcAg-CS polypeptides purified from S. typhimurium were particulate and displayed CS and HBc antigenicity, however, the HBc antigenicity was reduced compared to native recombinant HBcAg. Immunization of several mouse strains with HBcAg-CS1 and HBcAg-CS2 particles resulted in high titer, P.berghei- or P.falciparum-specific anti-CS antibodies representing all murine immunoglobulin G isotypes. The possible influence of carrier-specific immunosuppression was examined, and preexisting immunity to HBcAg did not significantly affect the immunogenicity of the CS epitopes within HBcAg-CS1 particles. Similarly, the choice of adjuvant did not significantly alter the immunogenicity of HBcAg-CS hybrid particles. Immunization in complete or incomplete Freund's adjuvant or alum resulted in equivalent anti-HBc and anti-CS humoral responses. Examination of T cell recognition of HBcAg-CS particles revealed that HBcAg-specific T cells were universally primed and CS-specific T cells were primed if the insert contained a CS-specific T cell recognition site. This indicates that the internal site in HBcAg is permissive for the inclusion of heterologous pathogen-specific T as well as B cell epitopes. Most importantly, 90 and 100% of BALB/c mice immunized with HBcAg-CS1 particles were protected against a P. berghei challenge infection in two independent experiments. Therefore, hybrid HBcAg-CS particles may represent a useful approach for future malaria vaccine development.Keywords
This publication has 33 references indexed in Scilit:
- Hepatitis B Virus Core Particles as a Vaccine Carrier MoietyInternational Reviews of Immunology, 1994
- General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.Proceedings of the National Academy of Sciences, 1985
- Rationale for Development of a Synthetic Vaccine Against Plasmodium falciparum MalariaScience, 1985
- Hemagglutination assay of polypeptide coded by the pre-S region of hepatitis B virus DNA with monoclonal antibody: correlation of pre-S polypeptide with the receptor for polymerized human serum albumin in serums containing hepatitis B antigens.The Journal of Immunology, 1985
- Immunochemical structure of hepatitis B e antigen in the serum.The Journal of Immunology, 1983
- Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax.Journal of Experimental Medicine, 1982
- Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responsesJournal of Experimental Medicine, 1982
- Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies.The Journal of Immunology, 1982
- Plasmodium berghei: The spleen in sporozoite-induced immunity to mouse malariaExperimental Parasitology, 1976
- Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity.1969